The Village of Roslyn Board of Trustees approved a new farm-to-table restaurant for Old Northern Boulevard and advanced ...
ImmunityBio commands a premium valuation on the promise of Anktiva, a chemo-free immunotherapy platform showing early efficacy and manageable safety. Learn more about IBRX stock here.
Russia is selling a story of inevitable victory and future profit. The facts tell a different story—of strain, attrition, and vulnerability.
Nutrien Ltd. (TSX and NYSE: NTR) announced today its fourth quarter 2025 results, with net earnings of $0.58 billion ($1.18 diluted net earnings per share). Fourth quarter 2025 adjusted EBITDA1 was $1 ...
Brex reports T-accounts as essential visual tools in accounting that clarify how transactions impact debits and credits, ensuring balance in financial records.
The convergence of accelerating inflation and heightened tariff costs creates optimal conditions for adopting LIFO, but taxpayers need to understand the benefits and act promptly.
Q4 2025 Earnings Call February 18, 2026 4:00 AM EST Good morning, everyone, and thank you for joining our full year 2025 results presentation. This is Abel Arbat speaking from the Capital Markets team ...
Triple Flag Precious Metals Corp. (with its subsidiaries, "Triple Flag" or the "Company") (TSX: TFPM, NYSE: TFPM) announced its results for the fourth quarter and full year of 2025 and declared a ...
Allied Market Research published a report, titled, "Angioplasty Balloons Market by Type (Normal Balloons, Drug Eluting ...
Get a closer look at the biotech ophthalmology landscape to discover exactly how companies are approaching the treatment of eye diseases.
Black Friday has become synonymous with deals, but it also means crowds, chaos, and camping out in parking lots. The Overstock Center in Bridgeview, Illinois offers something better: Black Friday ...
Not too long ago, foldable phones were something you’d only see in sci-fi movies. Now, they’re everywhere, with more models ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results